Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease.

Jordan LC, Juttukonda MR, Kassim AA, DeBaun MR, Davis LT, Pruthi S, Patel NJ, Lee CA, Waddle SL, Donahue MJ.

Am J Hematol. 2019 Mar 5. doi: 10.1002/ajh.25455. [Epub ahead of print] No abstract available.

PMID:
30838684
2.

Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease.

Day ME, Stimpson SJ, Rodeghier M, Ghafuri D, Callaghan M, Zaidi AU, Hannan B, Kassim A, James AH, DeBaun MR, Sharma D.

South Med J. 2019 Mar;112(3):174-179. doi: 10.14423/SMJ.0000000000000949.

PMID:
30830232
3.

Acute Vaso-Occlusive Pain is Temporally Associated with the Onset of Menstruation in Women with Sickle Cell Disease.

Sharma D, Day ME, Stimpson SJ, Rodeghier M, Ghafuri D, Callaghan M, Zaidi AU, Hannan B, Kassim A, Zempsky W, Wellons M, James A, Bruehl S, DeBaun MR.

J Womens Health (Larchmt). 2019 Feb;28(2):162-169. doi: 10.1089/jwh.2018.7147. Epub 2019 Jan 16.

PMID:
30648915
4.

Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis.

DeBaun MR, Ghafuri DL, Rodeghier M, Maitra P, Chaturvedi S, Kassim A, Ataga KI.

Blood. 2019 Feb 7;133(6):615-617. doi: 10.1182/blood-2018-10-880575. Epub 2018 Dec 10. No abstract available.

PMID:
30530750
5.

Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.

de la Fuente J, Dhedin N, Koyama T, Bernaudin F, Kuentz M, Karnik L, Socié G, Culos KA, Brodsky RA, DeBaun MR, Kassim AA.

Biol Blood Marrow Transplant. 2018 Nov 28. pii: S1083-8791(18)30772-9. doi: 10.1016/j.bbmt.2018.11.027. [Epub ahead of print]

PMID:
30500440
6.

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.

Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson A, Kalinyak K, DeBaun M, Treadwell M.

Hematology. 2019 Dec;24(1):189-198. doi: 10.1080/16078454.2018.1549801.

PMID:
30479187
7.

Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.

Oppong SA, Asare EV, Olayemi E, Boafor T, Dei-Adomakoh Y, Swarry-Deen A, Mensah E, Osei-Bonsu Y, Crabbe S, Musah L, Hayfron-Benjamin C, Covert B, Kassim AA, James A, Rodeghier M, Audet C, DeBaun MR.

Am J Hematol. 2019 Feb;94(2):223-230. doi: 10.1002/ajh.25356. Epub 2018 Dec 5.

PMID:
30456766
8.

Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.

Cronin RM, Dorner TL, Utrankar A, Allen W, Rodeghier M, Kassim AA, Jackson GP, DeBaun MR.

Pain Med. 2018 Oct 16. doi: 10.1093/pm/pny194. [Epub ahead of print]

PMID:
30329108
9.

Differential cerebral hemometabolic responses to blood transfusions in adults and children with sickle cell anemia.

Juttukonda MR, Lee CA, Patel NJ, Davis LT, Waddle SL, Gindville MC, Pruthi S, Kassim AA, DeBaun MR, Donahue MJ, Jordan LC.

J Magn Reson Imaging. 2019 Feb;49(2):466-477. doi: 10.1002/jmri.26213. Epub 2018 Oct 15.

PMID:
30324698
10.

Silent infarct is a risk factor for infarct recurrence in adults with sickle cell anemia.

Jordan LC, Kassim AA, Donahue MJ, Juttukonda MR, Pruthi S, Davis LT, Rodeghier M, Lee CA, Patel NJ, DeBaun MR.

Neurology. 2018 Aug 21;91(8):e781-e784. doi: 10.1212/WNL.0000000000006047. Epub 2018 Jul 27.

PMID:
30054441
11.

Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort study.

Chaturvedi S, Ghafuri DL, Jordan N, Kassim A, Rodeghier M, DeBaun MR.

Am J Hematol. 2018 Sep;93(9):1153-1160. doi: 10.1002/ajh.25202. Epub 2018 Jul 30.

PMID:
29981283
12.

Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers.

Cronin RM, Mayo-Gamble TL, Stimpson SJ, Badawy SM, Crosby LE, Byrd J, Volanakis EJ, Kassim AA, Raphael JL, Murry VM, DeBaun MR.

BMC Hematol. 2018 Jun 8;18:12. doi: 10.1186/s12878-018-0106-3. eCollection 2018.

13.

Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.

Clark CA, Mosse CA, Chen H, Byrne M, Chinratanalab W, Engelhardt BG, Goodman SA, Harrell SL, Kassim AA, Savani BN, Sengsayadeth S, Jagasia M, Cornell RF.

Bone Marrow Transplant. 2018 Dec;53(12):1589-1592. doi: 10.1038/s41409-018-0241-2. Epub 2018 Jun 18. No abstract available.

PMID:
29915217
14.

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

McDonald MK, Culos KA, Gatwood KS, Prow C, Chen H, Savani BN, Byrne M, Kassim AA, Engelhardt BG, Jagasia M, Satyanarayana G.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2081-2087. doi: 10.1016/j.bbmt.2018.04.031. Epub 2018 May 9.

PMID:
29753159
15.

Technology use and preferences to support clinical practice guideline awareness and adherence in individuals with sickle cell disease.

Utrankar A, Mayo-Gamble TL, Allen W, Novak L, Kassim AA, Bonnet K, Schlundt D, Murry VM, Jackson GP, DeBaun M, Cronin RM.

J Am Med Inform Assoc. 2018 Aug 1;25(8):976-988. doi: 10.1093/jamia/ocy036.

PMID:
29741695
16.

Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.

Aslam HM, Yousuf S, Kassim A, Iqbal SM, Hashmi SK.

Bone Marrow Transplant. 2018 Nov;53(11):1390-1400. doi: 10.1038/s41409-018-0193-6. Epub 2018 May 4.

PMID:
29728697
17.

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.

Huang J, Phillips S, Byrne M, Chinratanalab W, Engelhardt BG, Goodman SA, Harrell SL, Jagasia M, Kassim A, Rawling KT, Savani BN, Sengsayadeth S, Cornell RF.

Bone Marrow Transplant. 2018 Jun;53(6):701-707. doi: 10.1038/s41409-018-0177-6. Epub 2018 Apr 27.

PMID:
29703965
18.

A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting.

Asare EV, Olayemi E, Boafor T, Dei-Adomakoh Y, Mensah E, Osei-Bonsu Y, Crabbe S, Musah L, Hayfron-Benjamin C, Covert-Greene B, Kassim AA, James A, Rodeghier M, DeBaun MR, Oppong SA.

Am J Hematol. 2018 Jul;93(7):E167-E170. doi: 10.1002/ajh.25115. Epub 2018 Apr 28. No abstract available.

PMID:
29659044
19.

Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease.

Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson AA, Kalinyak K, DeBaun MR, Treadwell M.

Hematology. 2018 Oct;23(9):683-691. doi: 10.1080/10245332.2018.1457200. Epub 2018 Mar 29.

PMID:
29595096
20.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Gatwood KS, Culos KA, Binari LA, Engelhardt BG, Kassim A, Byrne MT, Goodman SA, Chinratanalab W, Sengsayadeth SM, Greer JP, Jagasia M, Savani BN.

Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14. No abstract available.

PMID:
29540851
21.

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, Neville K, Kirkham FJ, Shyr Y, Phillips S, Covert BV, Kassim AA, Jordan LC, Aliyu MH, DeBaun MR.

Am J Hematol. 2018 Mar;93(3):E83. doi: 10.1002/ajh.25012. Epub 2018 Feb 2. No abstract available.

22.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Castillo J, Chandler JC, Costello C, Faiman M, Fung HC, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kang Y, Kassim A, Liedtke M, Malek E, Martin T, Neppalli VT, Omel J, Raje N, Singhal S, Somlo G, Stockerl-Goldstein K, Weber D, Yahalom J, Kumar R, Shead DA.

J Natl Compr Canc Netw. 2018 Jan;16(1):11-20. doi: 10.6004/jnccn.2018.0002.

PMID:
29295877
23.

Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia.

Juttukonda MR, Donahue MJ, Davis LT, Gindville MC, Lee CA, Patel NJ, Kassim AA, Pruthi S, Hendrikse J, Jordan LC.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17746808. doi: 10.1177/0271678X17746808. [Epub ahead of print]

PMID:
29260615
24.

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Kennedy VE, Chen H, Savani BN, Greer J, Kassim AA, Engelhardt BG, Goodman S, Sengsayadeth S, Chinratanalab W, Jagasia M.

Biol Blood Marrow Transplant. 2018 Jan;24(1):150-155. doi: 10.1016/j.bbmt.2017.08.029. Epub 2017 Aug 30.

25.

History of parvovirus B19 infection is associated with silent cerebral infarcts.

Ogunsile FJ, Currie KL, Rodeghier M, Kassim A, DeBaun MR, Sharma D.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26767. Epub 2017 Aug 17.

PMID:
28834316
26.

Hematopoietic stem cell transplantation for acute myeloid leukemia: A review.

Kassim AA, Savani BN.

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):245-251. doi: 10.1016/j.hemonc.2017.05.021. Epub 2017 Jun 20. Review.

27.

Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.

Kassim AA, Sharma D.

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):259-266. doi: 10.1016/j.hemonc.2017.05.008. Epub 2017 Jun 15. Review.

28.

Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.

Oke O, Sethi T, Goodman S, Phillips S, Decker I, Rubinstein S, Concepcion B, Horst S, Jagasia M, Kassim A, Harrell SL, Langone A, Lenihan D, Rawling KT, Slosky D, Cornell RF.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1473-1477. doi: 10.1016/j.bbmt.2017.05.020. Epub 2017 May 22.

29.

Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting.

Asare EV, Olayemi E, Boafor T, Dei-Adomakoh Y, Mensah E, Ghansah H, Osei-Bonsu Y, Crabbe S, Musah L, Hayfron-Benjamin C, Covert B, Kassim AA, James A, Rodeghier M, DeBaun MR, Oppong SA.

Am J Hematol. 2017 Sep;92(9):872-878. doi: 10.1002/ajh.24790. Epub 2017 Jun 9.

30.

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, Neville K, Kirkham FJ, Shyr Y, Phillips S, Covert BV, Kassim AA, Jordan LC, Aliyu MH, DeBaun MR.

Am J Hematol. 2017 Aug;92(8):780-788. doi: 10.1002/ajh.24770. Epub 2017 Jun 15. Erratum in: Am J Hematol. 2018 Mar;93(3):E83.

31.

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Faiman M, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Liedtke M, Martin T, Omel J, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2017 Feb;15(2):230-269.

PMID:
28188192
32.

PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.

Debaun MR, Galadanci NA, Kassim AA, Jordan LC, Phillips S, Aliyu MH.

Trans Am Clin Climatol Assoc. 2016;127:17-33.

33.

Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease.

Brodsky MA, Rodeghier M, Sanger M, Byrd J, McClain B, Covert B, Roberts DO, Wilkerson K, DeBaun MR, Kassim AA.

Am J Med. 2017 May;130(5):601.e9-601.e15. doi: 10.1016/j.amjmed.2016.12.010. Epub 2017 Jan 5.

PMID:
28065771
34.

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.

Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA.

Cornea. 2017 Feb;36(2):258-263. doi: 10.1097/ICO.0000000000001109.

PMID:
28060078
35.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG.

Biol Blood Marrow Transplant. 2017 Mar;23(3):529-532. doi: 10.1016/j.bbmt.2016.12.627. Epub 2016 Dec 21.

36.

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P.

Biol Blood Marrow Transplant. 2017 Feb;23(2):269-277. doi: 10.1016/j.bbmt.2016.11.011. Epub 2016 Nov 15.

37.

Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.

Chaturvedi S, Labib Ghafuri D, Kassim A, Rodeghier M, DeBaun MR.

Am J Hematol. 2017 Feb;92(2):125-130. doi: 10.1002/ajh.24598.

38.

Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.

Bello-Manga H, DeBaun MR, Kassim AA.

Expert Rev Hematol. 2016 Nov;9(11):1031-1042. Epub 2016 Oct 17. Review.

PMID:
27677923
39.

Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype.

Chaturvedi S, Ghafuri DL, Glassberg J, Kassim AA, Rodeghier M, DeBaun MR.

Am J Hematol. 2016 Dec;91(12):1185-1190. doi: 10.1002/ajh.24539. Epub 2016 Oct 3.

40.

Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans-regional survey.

Cronin RM, Hankins JS, Adams-Graves P, Thompson AA, Kalinyak K, Byrd J, McClain B, Kassim A, DeBaun M, Treadwell M.

Am J Hematol. 2016 Oct;91(10):E461-2. doi: 10.1002/ajh.24483. Epub 2016 Aug 4. No abstract available.

41.

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1801-1807. doi: 10.1016/j.bbmt.2016.06.029. Epub 2016 Jul 1.

42.

Cognitive deficits are associated with unemployment in adults with sickle cell anemia.

Sanger M, Jordan L, Pruthi S, Day M, Covert B, Merriweather B, Rodeghier M, DeBaun M, Kassim A.

J Clin Exp Neuropsychol. 2016 Aug;38(6):661-71. doi: 10.1080/13803395.2016.1149153.

PMID:
27167865
43.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2016 Apr;14(4):389-400.

44.

Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies.

Alfraih F, Aljurf M, Fitzhugh CD, Kassim AA.

Semin Hematol. 2016 Apr;53(2):120-8. doi: 10.1053/j.seminhematol.2016.01.001. Epub 2016 Jan 15. Review.

PMID:
27000737
45.

Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia.

Kassim AA, Pruthi S, Day M, Rodeghier M, Gindville MC, Brodsky MA, DeBaun MR, Jordan LC.

Blood. 2016 Apr 21;127(16):2038-40. doi: 10.1182/blood-2016-01-694562. Epub 2016 Mar 3. No abstract available.

46.

Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia.

Jordan LC, Gindville MC, Scott AO, Juttukonda MR, Strother MK, Kassim AA, Chen SC, Lu H, Pruthi S, Shyr Y, Donahue MJ.

Brain. 2016 Mar;139(Pt 3):738-50. doi: 10.1093/brain/awv397. Epub 2016 Jan 27.

47.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.

Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE Jr.

Haematologica. 2016 May;101(5):e204-8. doi: 10.3324/haematol.2015.139501. Epub 2016 Jan 27. No abstract available.

48.

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.

Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, Wang L, Fonnesbeck C, Jagasia M.

Biol Blood Marrow Transplant. 2016 Mar;22(3):528-35. doi: 10.1016/j.bbmt.2015.12.003. Epub 2015 Dec 17.

49.

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators.

Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5.

50.

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2015 Nov;13(11):1398-435.

Supplemental Content

Loading ...
Support Center